Ipsen

IpsenIpsen
Ipsen

Ipsen

Global biopharmaceutical company focused on oncology, rare diseases, and neuroscience.

DR 761929Active6664Paris, France
Rate

About

Ipsen is a global biopharmaceutical company focused on improving people's lives and health outcomes by accelerating its momentum and boosting its pipeline to bring innovative medicines to patients. The company concentrates its efforts on oncology, rare disease, and neuroscience, areas with high unmet medical needs. Ipsen serves patients and society by developing new therapies and fostering valuable collaborations.
HEADCOUNT
6664
DOMAIN RATING
76
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Ipsen do?

Ipsen is a global biopharmaceutical company focused on improving people's lives and health outcomes by accelerating its momentum and boosting its pipeline to bring innovative medicines to patients. The company concentrates its efforts on oncology, rare disease, and neuroscience, areas with high unmet medical needs. Ipsen serves patients and society by developing new therapies and fostering valuable collaborations.

Where is Ipsen headquartered?

Ipsen is headquartered in Paris, France.

When was Ipsen founded?

Ipsen was founded in 1929.

What industry does Ipsen operate in?

Ipsen operates in Biotech, MedTech, HealthTech, Genomics, Drug Discovery, Clinical Trials.

How many employees does Ipsen have?

Ipsen has approximately 6664 people on record.

What is Ipsen's revenue?

StartupHub estimates Ipsen's annual revenue at $1.1B (range $784.9M to $1.5B, 63% confidence), based on comparable companies in the sector.